Predictive value of early interim FDG-PET according to stage and extranodal disease
. | PET2 (qualitative) . | . | . | |
|---|---|---|---|---|
. | Negative . | Positive . | Total . | |
| Early stage (I-IIA) | ||||
| Progression | ||||
| No | 26 | 4 | 30 | |
| Yes | 0 | 1 | 1 | |
| Total | 26 | 5 | 31 | |
| Advanced stage (IIB-IV) | ||||
| Progression | ||||
| No | 32 | 1 | 33 | |
| Yes | 3 | 10 | 13 | |
| Total | 35 | 11 | 46 | |
| No extranodal disease | ||||
| Progression | ||||
| No | 51 | 5 | 56 | |
| Yes | 3 | 4 | 7 | |
| Total | 54 | 9 | 63 | |
| Extranodal disease | ||||
| Progression | ||||
| No | 7 | 0 | 7 | |
| Yes | 0 | 7 | 7 | |
| Total | 35 | 7 | 14 | |
. | PET2 (qualitative) . | . | . | |
|---|---|---|---|---|
. | Negative . | Positive . | Total . | |
| Early stage (I-IIA) | ||||
| Progression | ||||
| No | 26 | 4 | 30 | |
| Yes | 0 | 1 | 1 | |
| Total | 26 | 5 | 31 | |
| Advanced stage (IIB-IV) | ||||
| Progression | ||||
| No | 32 | 1 | 33 | |
| Yes | 3 | 10 | 13 | |
| Total | 35 | 11 | 46 | |
| No extranodal disease | ||||
| Progression | ||||
| No | 51 | 5 | 56 | |
| Yes | 3 | 4 | 7 | |
| Total | 54 | 9 | 63 | |
| Extranodal disease | ||||
| Progression | ||||
| No | 7 | 0 | 7 | |
| Yes | 0 | 7 | 7 | |
| Total | 35 | 7 | 14 | |